Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence

NCT03219372 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Study discontinued due to low accrual.

Conditions

Hepatocellular Carcinoma
Liver Cirrhoses

Interventions

DRUG: Pravastatin Pill
DRUG: Placebo Oral Tablet

Sponsor

Cedars-Sinai Medical Center

Collaborators

[object Object]
[object Object]